DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) - KALOBIOS PHARMACEUTICALS INC ownership

KALOBIOS PHARMACEUTICALS INC's ticker is KBIO and the CUSIP is 48344T100. A total of 24 filers reported holding KALOBIOS PHARMACEUTICALS INC in Q1 2015. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) ownership history of KALOBIOS PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2014$3,956,000
-17.0%
2,286,783
-25.6%
0.14%
-18.4%
Q3 2014$4,766,000
-25.0%
3,074,972
+10.3%
0.17%
-32.0%
Q2 2014$6,354,000
-15.9%
2,786,7830.0%0.26%
-16.9%
Q1 2014$7,552,0002,786,7830.31%
Other shareholders
KALOBIOS PHARMACEUTICALS INC shareholders Q1 2015
NameSharesValueWeighting ↓
Opus Point Partners Management, LLC 746,467$358,0000.28%
HARBOURVEST PARTNERS LLC 57,604$28,0000.01%
PRIMECAP MANAGEMENT CO/CA/ 4,327,600$2,077,0000.00%
Renaissance Technologies 564,673$271,0000.00%
VALLEY WEALTH MANAGERS, INC. 15,861$8,0000.00%
CITIGROUP INC 2,745$1,0000.00%
GOLDMAN SACHS GROUP INC 14,456$7,0000.00%
BLAIR WILLIAM & CO/IL 53,635$25,0000.00%
CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM 86,700$42,0000.00%
Tower Research Capital LLC (TRC) 3,055$1,0000.00%
View complete list of KALOBIOS PHARMACEUTICALS INC shareholders